She added that this is “a straightforward testing strategy which can be immediately implemented to impact not only the patients themselves and their risk of cancer, but also their family members and their risk of cancer.”
This study was funded by Romeo Milio Lynch Syndrome Foundation, the Marie-Josee and Henry R. Kravis Center for Molecular Oncology, the Robert and Kate Niehaus Center for Inherited Cancer Genomics, the Fieldstone Family Fund, Stand Up to Cancer Colorectal Cancer Dream Team Translational Research Grant and the NIH/NCI Cancer Center Support Grant. Dr. Stadler reported consulting or advisory roles on the part of an immediate family member for Allergan, Genentech/Roche, Regeneron, Optos, and Adverum.
SOURCE: Schwark A et al., ASCO 2018 LBA1509.